MBWM vs REGN · P/E 10, rev $172.1M vs P/E 14, rev $4.29B
Mercantile Bank Corporation (MBWM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Mercantile Bank Corporation (MBWM) is a banks - regional company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MBWM revenue for 2026-06-30 was $172.1M. Net income was $48.6M. MBWM currently screens at market cap $808.7M and trailing P/E 10.4.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MBWM currently screens at market cap $808.7M and trailing P/E 10.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MBWM and REGN stock pages for the full models.
Not investment advice.